US FirstQuarter GDP Revised Down to 16 What the Revised Data Signals About Economic Momentum Kazatomprom Q3 Production Surges 17 Signaling Strong Uranium Supply AIDriven Drug Discovery May Accelerate Treatments for Brain Conditions Lack of Transparency in Estate Management Raises Red Flags for Beneficiaries Key Market Movers SpaceX IPO Speculation Nvidia Earnings and Bezos AI Bubble Comments Highlighted in CNBCs Morning Squawk Waymo Halts Robotaxi Services in Five US Cities After Flood Incidents Stem Inc Q1 2026 Earnings EPS Beat Drives Stock Higher Despite Challenging Operating Environment DTI Q1 2026 Earnings EPS Misses Expectations as Stock Declines Americold Realty Trust COLD Q1 2026 Earnings Narrower Loss and Positive Surprise Drive Shares Higher HomeTrust Bancshares Q1 2026 Earnings Strong Earnings Beat Driven by Improved Net Interest Margin SNBR Q1 2026 Earnings Staggering EPS Miss Signals Deep Operational Challenges COLM Q1 2026 Earnings EPS Soars Past Estimates with 8066 Surprise PolyPid Shares Slide Amid Light Trading Testing Key Support Levels PYPD Axiom Intelligence Acquisition Corp AXIN Holds Steady at 1022 as SPAC Consolidation Continues Cheniere Energy Partners CQP Holds Steady Modest Gains Amid Sector Stability AAR Corp Holds Steady Near 11256 Assessing Support and Resistance Levels Virginia National Bankshares VABK Edges Lower Amid Consolidation Near Support FFBC Q1 2026 Earnings EPS Beats Estimates by 8 Stock Slightly Lower Park Aerospace Q1 2026 Earnings EPS of 015 Reported Stock Advances 488 ORIO Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Discipline Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs Oxford Square Capital Corp Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines RRC Q1 2026 Earnings EPS Surges Past Estimates by 19 Stock Slips as Market Weighs Sector Headwinds Trump Refiles 10 Billion Lawsuit Against Wall Street Journal Over Epstein Report PMTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Rally Aprea Therapeutics APRE Edges Higher Amid Light Trading Key Resistance at 099 in Focus